SRx Health Solutions, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
SRXH$0.87+7.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
ITEM 6. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
The following exhibits are filed herewith.
EXHIBIT INDEX
| Exhibit | Exhibit Description | Form | File No. | Exhibit | Filing date |
|---|---|---|---|---|---|
| 2.1 | Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc. and Bona Vida, Inc. | 8-K | 333-161943 | 2.1 | 05/10/2019 |
| 2.2 | First Amendment to Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc., and Bona Vida, Inc., dated May 3, 2019 | 8-K | 333-161943 | 2.2 | 05/10/2019 |
| 2.3 | Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC | 8-K | 333-161943 | 2.3 | 05/10/2019 |
| 2.4 | First Amendment to Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC, dated May 6, 2019 | 8-K | 333-161943 | 2.4 | 05/10/2019 |
| 2.5 | Amended and Restated Stock Purchase Agreement, dated December 18, 2019, by and among the Company, Halo, Purely For Pets, Inc., Thriving Paws, LLC and HH-Halo LP | 8-K | 333-161943 | 2.1 | 12/26/2019 |
| 2.6 | Agreement and Plan of Merger, dated July 28, 2022, by and among TruPet LLC and Halo, Purely for Pets, Inc. | 10-Q | 001-40477 | 2.6 | 08/11/2022 |
| 3.1 | Certificate of Incorporation, dated January 1, 2019 | 10-Q | 333-161943 | 3.1 | 04/15/2019 |
| 3.2 | Certificate of Amendment to Certificate of Incorporation, dated February 1, 2019 | 10-Q | 333-161943 | 3.2 | 04/15/2019 |
| 3.3 | Certificate of Amendment to Certificate of Incorporation, dated March 13, 2019 | 8-K | 333-161943 | 3.1 | 03/20/2019 |
| 3.4 | Certificate of Amendment to Certificate of Incorporation, dated April 18, 2019 | 10-KT | 333-161943 | 3.5 | 07/25/2019 |
| 3.5 | Certificate of Amendment to Certificate of Incorporation, dated July 30, 2020 | 8-K | 333-161943 | 99.1 | 07/30/2020 |
| 3.6 | Certificate of Merger of Sport Endurance, Inc. with and into the Company | 10-Q | 333-161943 | 3.4 | 04/15/2019 |
| 3.7 | Certificate of Amendment to Certificate of Incorporation, dated April 24, 2025 | 8-K | 001-40477 | 3.6 | 04/30/2025 |
| 3.8 | Certificate of Designation for Series A Special Voting Preferred Stock, filed April 24, 2025 | 8-K | 001-40477 | 3.8 | 04/30/2025 |
| 3.9 | Certificate of Designations of Rights and Preferences and Limitations of the Series A Convertible Preferred Stock, filed October 27, 2025. | 8-K | 001-40477 | 3.1 | 10/31/2025 |
| 3.10 | Certificate of Amendment to Certificate of Incorporation, dated November 19, 2025 | 8-K | 001-40477 | 3.1 | 11/20/2025 |
| 3.11 | Series B Certificate of Designations | 8-K | 001-40477 | 3.1 | 03/18/2026 |
| 3.12 | Bylaws | 10-Q | 333-161943 | 3.5 | 04/15/2019 |
| 4.1† | Better Choice Company Inc. Amended and Restated 2019 Incentive Award Plan | 10-K | 333-161943 | 10.19 | 05/04/2020 |
| 4.2† | Form of 2019 Incentive Award Plan Stock Option Agreement | S-1 | 333-234349 | 10.7 | 10/28/2019 |
| 10.1† | Form of Indemnification Agreement by and among the Company and its officers and directors | S-1 | 333-234349 | 10.8 | 10/28/2019 |
| 10.2 | Arrangement Agreement, dated September 3, 2024, between Better Choice Company Inc., and SRx Health Solutions, Inc., as amended December 6, 2024, January 24, 2025 and February 25, 2025 | 8-K | 001-40477 | 10.1 | 09/09/2024 |
| 10.3 | Common Share Purchase Agreement by and between the Company and the buyers named therein, dated July 7, 2025 | 8-K | 001-40477 | 10.1 | 07/15/2025 |
| 10.4 | Registration Rights Agreement by and between the Company and the buyers named therein, dated July 7, 2025 | 8-K | 001-40477 | 10.2 | 07/15/2025 |
| 10.5 | Securities Purchase Agreement, dated as of July 8, 2025, by and among the Company and the investors named therein | 8-K | 001-40477 | 10.3 | 07/15/2025 |
| 10.6 | Security Agreement, dated as of July 8, 2025, by and between the Company, the Lead Investor and the other parties thereto | 8-K | 001-40477 | 10.6 | 07/15/2025 |
| 10.7 | Registration Rights Agreement (Convertible Note Financing), dated as of July 8, 2025, by and between the Company and the investors named therein | 8-K | 001-40477 | 10.7 | 07/15/2025 |
| 10.8 | Kent Cunningham Executive Employment Agreement, dated July 14, 2025 | 8-K | 001-40477 | 10.1 | 07/16/2025 |
| 10.9 | Carolina Martinez Amendment to Executive Employment Agreement, dated July 14, 2025 | 8-K | 001-40477 | 10.2 | 07/16/2025 |
| 10.10 | Settlement, Share Forfeiture and Mutual Release Agreement, dated August 14, 2025 | 8-K | 001-40477 | 10.1 | 08/14/2025 |
| 10.11 | Securities Purchase Agreement dated October 27, 2025 by and among the Company and the investors named therein. | 8-K | 001-40477 | 10.1 | 10/31/2025 |
| 10.12 | Registration Rights Agreement dated October 31, 2025 by and between the Company and the lead investor named therein. | 8-K | 001-40477 | 10.2 | 10/31/2025 |
| 10.13 | Amendment dated October 28, 2025 to Common Stock Purchase Agreement dated July 7, 2025 by and between the Company and the investor named therein. | 8-K | 001-40477 | 10.3 | 10/31/2025 |
| 10.14 | Share Exchange and Asset Transfer Agreement, dated December 16, 2025, by and among the Company and the other parties named therein. | 8-K | 001-40477 | 2.1 | 12/16/2025 |
| 10.15 | Series B Securities Purchase Agreement | 8-K | 001-40477 | 10.1 | 03/18/2026 |
| 10.16 | Series B Registration Rights Agreement | 8-K | 001-40477 | 10.2 | 03/18/2026 |
| 31.1 * | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2 * | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1 * | Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||||
| 101 * | The following materials from the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 formatted in Inline Extensible Business Reporting Language (“iXBRL”): (i) the Consolidated Statements of Operations, (ii) the Consolidated Balance Sheets, (iii) the Consolidated Statements of Stockholders’ Equity, (iv) the Consolidated Statements of Cash Flows and (v) related notes, tagged as blocks of text and including detailed tags. | ||||
| 104 * | Cover page from the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, formatted in iXBRL (included as Exhibit 101). | ||||
| † | Indicates a management contract or any compensatory plan, contract or arrangement. |
|---|---|
| * | Filed or furnished herewith. |
| # | Certain schedules and similar attachments to this agreement have been omitted in accordance with Item 601(b)(5) of Regulation S-K. The Company will furnish copies of any schedules or similar attachments to the SEC upon request. |
| *** | Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.